CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- 4 Grant or award Chief Medical Officer acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 45,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 147,791 shares (grant or award)
- 4 Open-market sale Director sold 35,297 shares at an average $13.21 ($466,154)
- 4 Open-market sale Chief Accounting Officer sold 1,108 shares at $12.16 ($13,473)
- 4 Open-market sale Chief Scientific Officer sold 3,609 shares at $12.16 ($43,885)
- 4 Open-market sale President and CEO sold 4,786 shares at $12.16 ($58,198)
- 4 Open-market sale President and CEO sold 4,403 shares at $11.89 ($52,352)
- 4 Open-market sale Chief Financial Officer sold 5,134 shares at $11.89 ($61,043)
- 4 Open-market sale Chief Scientific Officer sold 4,592 shares at $11.89 ($54,599)
- 4 Open-market sale Chief Medical Officer sold 5,685 shares at $11.89 ($67,595)
- 4 Open-market sale Chief Accounting Officer sold 1,016 shares at $11.89 ($12,080)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Accounting Officer sold 230 shares at $9.89 ($2,275)
- 4 Open-market buy Director bought 30,000 shares at $7.57 ($227,010)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
Page 2 of 15 · 285 filings